110 related articles for article (PubMed ID: 29516890)
1. Identification and development of novel indazole derivatives as potent bacterial peptidoglycan synthesis inhibitors.
Malapati P; Krishna VS; Dharmarajan S
Int J Mycobacteriol; 2018; 7(1):76-83. PubMed ID: 29516890
[TBL] [Abstract][Full Text] [Related]
2. Lead identification and optimization of bacterial glutamate racemase inhibitors.
Malapati P; Siva Krishna V; Nallangi R; Meda N; Reshma Srilakshmi R; Sriram D
Bioorg Med Chem; 2018 Jan; 26(1):177-190. PubMed ID: 29239770
[TBL] [Abstract][Full Text] [Related]
3. Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors.
Malapati P; Krishna VS; Nallangi R; Srilakshmi RR; Sriram D
Eur J Med Chem; 2018 Feb; 145():23-34. PubMed ID: 29310027
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
[TBL] [Abstract][Full Text] [Related]
6. Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis.
Nguyen PC; Delorme V; Bénarouche A; Guy A; Landry V; Audebert S; Pophillat M; Camoin L; Crauste C; Galano JM; Durand T; Brodin P; Canaan S; Cavalier JF
Bioorg Chem; 2018 Dec; 81():414-424. PubMed ID: 30212765
[TBL] [Abstract][Full Text] [Related]
7. New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis.
Giacobbo BC; Pissinate K; Rodrigues-Junior V; Villela AD; Grams ES; Abbadi BL; Subtil FT; Sperotto N; Trindade RV; Back DF; Campos MM; Basso LA; Machado P; Santos DS
Eur J Med Chem; 2017 Jan; 126():491-501. PubMed ID: 27914363
[TBL] [Abstract][Full Text] [Related]
8. Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products.
Rodrigues Felix C; Gupta R; Geden S; Roberts J; Winder P; Pomponi SA; Diaz MC; Reed JK; Wright AE; Rohde KH
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607021
[TBL] [Abstract][Full Text] [Related]
9. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
10. 4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation.
Medapi B; Suryadevara P; Renuka J; Sridevi JP; Yogeeswari P; Sriram D
Eur J Med Chem; 2015 Oct; 103():1-16. PubMed ID: 26318054
[TBL] [Abstract][Full Text] [Related]
11. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
12. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.
Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V
Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240
[TBL] [Abstract][Full Text] [Related]
13. High-throughput screening of compounds library to identify novel inhibitors against latent Mycobacterium tuberculosis using streptomycin-dependent Mycobacterium tuberculosis 18b strain as a model.
Sharma S; Bhat R; Singh R; Sharma S; Wazir P; Singh PP; Vishwakarma RA; Khan IA
Tuberculosis (Edinb); 2020 Sep; 124():101958. PubMed ID: 32791471
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore.
Salunke SB; Azad AK; Kapuriya NP; Balada-Llasat JM; Pancholi P; Schlesinger LS; Chen CS
Bioorg Med Chem; 2015 May; 23(9):1935-43. PubMed ID: 25818768
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
[TBL] [Abstract][Full Text] [Related]
16. Identification, synthesis, and pharmacological evaluation of tetrahydroindazole based ligands as novel antituberculosis agents.
Guo S; Song Y; Huang Q; Yuan H; Wan B; Wang Y; He R; Beconi MG; Franzblau SG; Kozikowski AP
J Med Chem; 2010 Jan; 53(2):649-59. PubMed ID: 20000470
[TBL] [Abstract][Full Text] [Related]
17. Glutamate Racemase Is the Primary Target of β-Chloro-d-Alanine in Mycobacterium tuberculosis.
Prosser GA; Rodenburg A; Khoury H; de Chiara C; Howell S; Snijders AP; de Carvalho LP
Antimicrob Agents Chemother; 2016 Oct; 60(10):6091-9. PubMed ID: 27480853
[TBL] [Abstract][Full Text] [Related]
18. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model.
Grant SS; Kawate T; Nag PP; Silvis MR; Gordon K; Stanley SA; Kazyanskaya E; Nietupski R; Golas A; Fitzgerald M; Cho S; Franzblau SG; Hung DT
ACS Chem Biol; 2013 Oct; 8(10):2224-34. PubMed ID: 23898841
[TBL] [Abstract][Full Text] [Related]
20. Quinoline Derivatives Kill Mycobacterium tuberculosis by Activating Glutamate Kinase.
Makafe GG; Hussain M; Surineni G; Tan Y; Wong NK; Julius M; Liu L; Gift C; Jiang H; Tang Y; Liu J; Tan S; Yu Z; Liu Z; Lu Z; Fang C; Zhou Y; Zhang J; Zhu Q; Liu J; Zhang T
Cell Chem Biol; 2019 Aug; 26(8):1187-1194.e5. PubMed ID: 31204286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
